Authors:
Wang, CS
Goulet, F
Auger, F
Tremblay, N
Germain, L
Tetu, B
Citation: Cs. Wang et al., Production of bioengineered cancer tissue constructs in vitro: Epithelium-mesenchyme heterotypic interactions, IN VITRO-AN, 37(7), 2001, pp. 434-439
Authors:
Wang, CS
Goulet, F
Tremblay, N
Germain, L
Auger, F
Tetu, B
Citation: Cs. Wang et al., Selective culture of epithelial cells from primary breast carcinomas usingirradiated 3T3 cells as feeder layer, PATH RES PR, 197(3), 2001, pp. 175-181
Authors:
Auger, FA
Pouliot, R
Tremblay, N
Guignard, R
Noel, P
Juhasz, J
Germain, L
Goulet, F
Citation: Fa. Auger et al., Multistep production of bioengineered skin substitutes: Sequential modulation of culture conditions, IN VITRO-AN, 36(2), 2000, pp. 96-103
Authors:
Wang, CS
Goulet, F
Lavoie, J
Drouin, R
Auger, F
Champetier, S
Germain, L
Tetu, B
Citation: Cs. Wang et al., Establishment and characterization of a new cell line derived from a humanprimary breast carcinoma, CANC GENET, 120(1), 2000, pp. 58-72
Authors:
Auger, FA
Rouabhia, M
Goulet, F
Berthod, F
Moulin, V
Germain, L
Citation: Fa. Auger et al., Tissue-engineered human skin substitutes developed from collagen-populatedhydrated gels: clinical and fundamental applications, MED BIO E C, 36(6), 1998, pp. 801-812